Join us as we address a number of topics that cover how further progress can be made toward drug manufacturing and quality objectives! Read more
Come hear about technological improvements that can have a positive impact on preventing drug shortages. Read more
Thought-provoking narratives give the reader heuristic lessons that underscore the risks involved with temperature-sensitive drug stewardship. Read more
Register today for this course that will give you the opportunity to apply current regulatory guidance to your environmental monitoring program as well as to implement improved environmental monitoring procedures. Read more
Following the conference, a renowned training course on the freeze-drying process and a workshop on the application of risk-based principles to the freeze-drying process will be offered. Read more
Contamination Control in Healthcare Product Manufacturing, Volume 3
Editors: Russell Madsen, Jeanne Moldenhauer Table of Contents
September PDA Letter: This issue looks at environmental and financial factors impacting the future of the LAL test on its 50th anniversary. Karen Ginsbury discusses proposed USP chapter <1115>. David Myatt looks at the increasing use of plant isolates, and Claire Briglia explores what to to look for when selecting a rapid method.
Key reasons you should attend the 2014 PDA/FDA Joint Regulatory conference on September 8-10 2014 in Washington D.C.
Copyright © PDA